NCT03821038 — Sepsis, Severe trial site landscape

Public-registry site landscape for NCT03821038, a Sepsis, Severe study sponsored by Revimmune. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03821038 (registry record)
Sponsor	Revimmune
Condition(s)	Sepsis, Severe
Phase	PHASE2
Listed sites	10
Site countries	United States, France

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03821038 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →